Polarean Imaging Plc is a medical drug-device combination company operating in the high resolution medical imaging market which develops equipment that enables existing MRI systems to achieve an improved level of pulmonary functional imaging.
Crowe acted as reporting accountant to the transaction, with our capital markets team led by Stephen Bullock and Mitesh Patelia.
"The Capital Markets team at Crowe were extremely professional and efficient throughout the transaction. We would certainly recommend them to other companies looking to list in London."
Richard Hullihen, CEO, Polarean Imaging Plc